Electrical Neuromodulation for Muscle Spasms
What You Need to Know Before You Apply
What is the purpose of this trial?
Muscle stiffness and muscle spasms are common after spinal cord injury. They can interfere with washing and dressing, moving between the bed and a wheelchair, walking, and sleep, and they can cause pain. Oral medications are the usual first-line treatment, but many people report limited benefit or side effects.
This study examines a non-surgical method called transcutaneous spinal stimulation. Surface electrodes are placed on the lower back and on the abdomen, and an electrical current is passed between them to activate nerve fibers entering the spinal cord.
Adults who have had a spinal cord injury and have muscle stiffness or spasms in the legs may participate. Each participant takes part in all parts of the study and serves as their own comparison. Participants attend four visits at one study site, about one week apart. The first visit is for consent and a clinical examination. At each of the next three visits, the participant receives one capsule containing tizanidine, baclofen, or an inactive substance (placebo), in an order assigned by chance. One hour later, the participant receives two 15-minute periods of spinal stimulation, one at 30 pulses per second and one at 75 pulses per second, also in an order assigned by chance. Neither the participant nor the person conducting the testing knows which capsule was taken.
Leg reflexes, muscle activity, and knee movement are measured before the capsule is taken, one hour after it is taken, during each period of stimulation, and after each period of stimulation. Clinical scales for stiffness and spasms are also scored. The study compares the two stimulation rates, compares stimulation with each medicine given alone, and examines whether adding stimulation to a medicine has a larger effect than stimulation alone.
Who Is on the Research Team?
Matthias J. Krenn, Ph.D.
Principal Investigator
University of Mississippi Medical Center
Are You a Good Fit for This Trial?
This trial is for adults with a spinal cord injury who have muscle stiffness or spasms in their legs. Participants must be able to attend four study visits and take part in all parts of the study.Inclusion Criteria
Exclusion Criteria
What Are the Treatments Tested in This Trial?
Interventions
- Baclofen
- Tizanidine
- Transcutaneous spinal stimulation at 30 Hz
- Transcutaneous spinal stimulation at 75 Hz
Trial Overview
The study tests two types of non-surgical electrical stimulation (at 30 Hz and 75 Hz) applied to the lower back, as well as oral medications baclofen, tizanidine, and placebo. Each participant tries all treatments in different combinations.
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
All participants receive every study condition in a within-subjects crossover design. Each participant attends one evaluation visit, followed by three data-collection visits spaced about one week apart. At each data collection visit, the participant takes a single oral capsule containing tizanidine 2 mg, baclofen 20 mg, or matched placebo, in an order assigned at random across the three visits. One hour after intake, the participant receives two 15-minute blocks of continuous transcutaneous spinal stimulation, one at 30 Hz and one at 75 Hz, in an order assigned at random within the visit. Stimulation intensity is set individually below the motor threshold determined from posterior root reflex recruitment curves. Neurophysiological and clinical assessments are performed before drug intake, one hour after drug intake, during the middle 5 minutes of each stimulation block, and 5 minutes after the end of each stimulation block.
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Mississippi Medical Center
Lead Sponsor
Methodist Rehabilitation Center
Collaborator
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.